Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SERPINB5 |
| Upstream (Parents) |
|---|
| (<<) TRIM16 → SERPINB5 |
| (<<) GCNT3 → SERPINB5 |
| (<<) LAMC2 → SERPINB5 |
| (<<) RAB25 → SERPINB5 |
| Downstream (Children) |
|---|
| SERPINB5 → PROL1 (>>) |
| SERPINB5 → TFAP2A (>>) |
| SERPINB5 → PI3 (>>) |
| SERPINB5 → NMU (>>) |
| SERPINB5 → MAGEA11 (>>) |
| SERPINB5 → SCEL (>>) |
| SERPINB5 → EDAR (>>) |
| SERPINB5 → ANP32E (>>) |
| SERPINB5 → DSG3 (>>) |
| SERPINB5 → SH3TC2 (>>) |
| SERPINB5 → TRIM16 (>>) |
| SERPINB5 → GCNT3 (>>) |
| SERPINB5 → TMPRSS3 (>>) |
| SERPINB5 → LYPD3 (>>) |
| SERPINB5 → TEF (>>) |
